PRME vs TYL · rev $4.6M vs P/E 89, rev $1.26B
Prime Medicine, Inc. Common Stock (PRME) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
PRME currently screens at market cap $570.8M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the PRME and TYL stock pages for the full models.
Not investment advice.